Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Graphene Functionalisation Capabilities

17 Mar 2014 07:00

RNS Number : 3620C
Oxford Advanced Surfaces Group PLC
17 March 2014
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 

OAS announces graphene functionalisation capabilities

 

Oxford Advanced Surfaces Group (OAS), the AIM listed technology developer targeting engineered materials and surface modification applications in multiple markets including automotive, aerospace, communications and renewable energy, announces that it is developing capabilities to functionalise graphene using its proprietary Onto™ technology platform.

 

OAS is now investigating the use of Onto™ to modify graphene chemically for multiple applications. The ability to modify both the dispersibility/affinity of the graphene for a solvent or coating, and to improve the chemical interaction and adhesion of the graphene within a coating, is a powerful tool in the production of commercially relevant graphene-based applications and products.

 

OAS is researching the applications and requirements for chemically modified graphene in areas such as composites and electronics. In addition OAS is actively seeking partners for co-development of commercial applications with both graphene suppliers/manufactures as well as end users, converters and specifiers.

 

Graphene holds massive promise. Possessing a unique portfolio of desirable properties, including excellent conductivity, mechanical strength, gas barrier, thermal and biocompatibility, graphene is an intriguing material. One of the obstacles to realising graphene's potential is the need to functionalise with the minimum disruption to the intrinsic properties. This can be achieved by the chemical modification of graphene to impart the desired chemical properties to the platelets. The use of functional graphene is a fundamental part of new product design and should be factored into the plan for the product in the earliest stages of development.

 

Philip Spinks, CEO, commented:

 

"This is a significant development in the OAS Onto™ toolkit and could open significant emerging markets for OAS and graphene manufacturers and potential end users."

 

Jon-Paul Griffiths, Technical Manager, commented:

 

"The use of graphene in applications such as electronics and composites is an exciting prospect as seen by the materials community. Success relies heavily on the ability to combine graphene with other materials using commercially accepted manufacturing processes. The chemical modification of graphene using the OntoTM technology platform provides a significant potential to open up commercial applications for this exciting material."

 

17 March 2014

 

Enquiries:

 

Oxford Advances Surfaces Group Plc

www.oxfordsurfaces.com

 

Philip Spinks, Chief Executive Officer T: 01865 854 807

 

W H Ireland Limited

www.wh-ireland.co.uk

 

John Wakefield T: 0117 945 3471

 

 

Editors' Note

Oxford Advanced Surfaces Group (OAS) is the AIM listed technology developer targeting engineered materials and surface modification applications in multiple markets including automotive, aerospace, communications and renewable energy. Our proprietary Onto™ highly reactive chemistry provides manufacturers with solutions for the surface functionalisation and adhesion promotion of coatings, inks and adhesives to difficult-to-bond substrates. Onto™ is processed from solution using typical wet process techniques and can be integrated into customer manufacturing lines for use in a wide range of surface modification applications for high-performance plastics, low surface energy polymers and composites.

Onto™ technology creates permanent bonding to surfaces through the use of highly reactive carbene chemistry. Carbenes can react with almost anything, even difficult-to-bond materials with limited or no functionality such as polyethylene, making Onto™ a diverse surface modification technology for a wide range of materials. The chemistry is flexible and can be manipulated to provide a variety of properties to a surface, giving it scope for use in a broad range of applications and markets.

At OAS, we have the expertise, know-how and facilities to design and synthesise Onto™ materials and formulations that provide functional surface treatments to meet specific performance and processing requirements. We currently have one development product available to the market, EP1000, and we are working on a range of product to address further identified manufacturing needs.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUQAWUPCGWC
Date   Source Headline
22nd Mar 201910:39 amRNSHolding(s) in Company
20th Mar 20197:00 amRNSDirectors' Shareholdings
19th Mar 20194:52 pmRNSReplacement - Total Voting Rights and Notice of...
19th Mar 20193:35 pmRNSHolding(s) in Company
19th Mar 20193:32 pmRNSHolding(s) in Company
15th Mar 20198:10 amRNSTotal Voting Rights and Notice of Results
12th Mar 20197:00 amRNSGrant of Options
11th Mar 201912:58 pmRNSResult of Meeting & Directorate Change
7th Mar 20199:00 amRNSIssue of Equity
25th Feb 20197:00 amRNSAcquisition, Placing & Waiver of Rule 9
14th Feb 20193:58 pmRNSHolding(s) in Company
6th Feb 20194:42 pmRNSHolding(s) in Company
6th Feb 20194:41 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSDisposal of SICM business
20th Dec 20187:00 amRNSUpdate, Conditional Acquisition & Proposed Placing
30th Nov 20187:00 amRNSPublication of Paper in leading Journal
6th Sep 20183:06 pmRNSExercise of Options and Issue of Equity
6th Sep 20187:00 amRNSInterim Results
15th Aug 20187:00 amRNSFurther Pioneer Agreements and Notice of Results
19th Jul 20187:00 amRNSPublication of Scientific Paper
11th Jun 20187:00 amRNSDirectorate Changes
11th Jun 20187:00 amRNSIssue of Equity
16th May 201811:45 amRNSResult of AGM, name change and new website
24th Apr 20187:00 amRNSDirector Dealing
19th Apr 20187:00 amRNSSecond Pioneer Agreement Signed
12th Apr 20187:00 amRNSFirst Pioneer Agreement Signed
5th Apr 20183:28 pmRNSDirector Dealing
28th Mar 20187:00 amRNSFinal results for the year ended 31 December 2017
6th Feb 20187:00 amRNSMoUs signed with pioneers
19th Jan 20189:00 amRNSPublication of Scientific Paper
17th Jan 20187:00 amRNSPublication of Scientific Paper
6th Dec 20177:00 amRNSDirector Dealing
4th Dec 20177:00 amRNSNew Share Option Scheme and Grant to PDMR
1st Dec 20171:01 pmRNSDirectors' Dealing
28th Nov 20179:47 amRNSDirector Dealing
22nd Nov 20175:50 pmRNSHolding(s) in Company
20th Nov 201711:02 amRNSHolding(s) in Company
8th Nov 20178:11 amRNSCompletion of Acquisition, Appointment of Director
3rd Nov 20177:00 amRNSAcquisition of OpenIOLabs Limited
4th Oct 20177:00 amRNSChange of Adviser
12th Sep 20177:00 amRNSHalf-year Report
19th May 201711:34 amRNSResult of AGM
26th Apr 20177:00 amRNSDirectorate Changes
28th Mar 20177:00 amRNSFinal Results
16th Feb 20177:00 amRNSDigital Chemistry to be performed in space
31st Jan 20178:03 amRNSAdvisory Committee
31st Jan 20177:00 amRNSPresentation at Healthcare Conference
9th Jan 20177:00 amRNSDigitalGlasswareT
15th Sep 20167:00 amRNSHalf-year Report
12th May 201611:45 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.